https://www.selleckchem.com/products/esi-09.html
elae of COVID-19. Hypofractionated whole breast irradiation (hWBI) and intraoperative radiotherapy (IORT) could be associated in breast cancer patients showing high-risk factors of local recurrence after breast conserving therapy (BSC). The aim of this trial was to evaluate, for the first time, the toxicity and cosmesis of hWBI after photon-IORT in high-risk patients treated by adjuvant chemotherapy. Thirty-one high-risk localized breast cancer patients treated by BCS, IORT (20Gy), and adjuvant chemotherapy were included from February 20
Like
Comment
Share
